Cash-crunched healthcare providers received their first emergency payments from the Department of Health and Human Services last month. So far, Congress has allocated a total of $175 billion in relief ...
The annual J.P. Morgan Healthcare Conference draws the attention of much of the healthcare industry, making the event a popular time to announce deals. Acquisition announcements were not as prolific ...
Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently ...
Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults ...
Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...
Democratic senators are investigating 10 insurers’ role in the Trump administration’s termination of 760,000 ACA enrollees’ ...
Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the ...
Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...
At MedCity INVEST Digital Health, experts from Jona, Labcorp and Evvy discussed the drivers of consumer diagnostics.
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule ...
In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...
The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results